Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohnen, N. I.
Right arrow Articles by Albin, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohnen, N. I.
Right arrow Articles by Albin, R. L.
Neurology 2000;54:1753-1759
© 2000 American Academy of Neurology
Articles

Decreased striatal monoaminergic terminals in Huntington disease

N. I. Bohnen, MD, PhD, R. A. Koeppe, PhD, P. Meyer, MD, E. Ficaro, PhD, K. Wernette, MSN, M. R. Kilbourn, PhD, D. E. Kuhl, MD, K. A. Frey, MD, PhD and R. L. Albin, MD

From the Departments of Internal Medicine (Division of Nuclear Medicine) (Drs. Bohnen, Koeppe, Meyer, Ficaro, Wernette, Kilbourn, Kuhl, and Frey), Neurology (Dr. Albin), The University of Michigan Medical School; and Geriatric Research, Education and Clinical Center (Dr. Albin), Veterans Administration Medical Center, Ann Arbor, MI.

Address correspondence and reprint requests to Dr. Roger L. Albin, Neuroscience Laboratory Building, 1103 E. Huron, Ann Arbor, MI 48104-1687.

OBJECTIVE: To evaluate the integrity of the dorsal striatal dopaminergic innervation in rigid and choreic Huntington disease (HD).

BACKGROUND: Some patients with HD have an akinetic-rigid phenotype. It has been suggested that nigrostriatal in addition to striatal pathology is present in this subgroup. The authors sought to determine whether in vivo measures of striatal vesicular monoamine transporter type-2 (VMAT2) binding could distinguish patients with akinetic-rigid (HDr) from typical choreiform (HDc) HD.

METHODS: Nineteen patients with HD (mean age 48 ± 16 years) and 64 normal controls (mean age 50 ± 14 years) underwent (+)-{alpha}-[11C]dihydrotetrabenazine (DTBZ) PET imaging. DTBZ blood to brain ligand transport (K1) and tissue to plasma distribution volume (DV) in the caudate nucleus, anterior putamen, and posterior putamen were normalized to the occipital cortex.

RESULTS: The normalized striatal specific DV was reduced in HDr (n = 6) when compared with controls: caudate nucleus -33% (p < 0.001), anterior putamen -56% (p < 0.0001), and posterior putamen -75% (p < 0.0001). Patients with HDc (n = 13) also had reduced striatal DV: caudate nucleus -6% (NS), anterior putamen -19% (p < 0.01), and posterior putamen -35% (p < 0.0001). Patients with HDr had significantly lower striatal (+)-{alpha}-[11C]DTBZ binding than HDc patients. After correction for tissue atrophy effects, normalized DV differences were less significant, with values somewhat increased in the caudate, slightly reduced in the anterior putamen, and moderately decreased in the posterior putamen. There were no significant regional differences in K1 reductions among caudate, anterior, and posterior putamen in HD.

CONCLUSIONS: Reduced striatal VMAT2 binding suggests nigrostriatal pathology in HD, most severely in the HDr phenotype. Striatal DV reductions were most prominent in the posterior putamen, similar to PD.

Key words: Dihydrotetrabenazine—Emission computed tomography—Huntington disease—Vesicular monoamine transporter




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M. Y. Heng, S. J. Tallaksen-Greene, P. J. Detloff, and R. L. Albin
Longitudinal Evaluation of the Hdh(CAG)150 Knock-In Murine Model of Huntington's Disease
J. Neurosci., August 22, 2007; 27(34): 8989 - 8998.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. J. Thieben, A. J. Duggins, C. D. Good, L. Gomes, N. Mahant, F. Richards, E. McCusker, and R. S. J. Frackowiak
The distribution of structural neuropathology in pre-clinical Huntington's disease
Brain, August 1, 2002; 125(8): 1815 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. L. Albin, R. A. Koeppe, R. D. Chervin, F. B. Consens, K. Wernette, K. A. Frey, and M. S. Aldrich
Decreased striatal dopaminergic innervation in REM sleep behavior disorder
Neurology, November 14, 2000; 55(9): 1410 - 1412.
[Abstract] [Full Text] [PDF]